Quick context: This article is about reading someone else's valuation critically. If you want to understand the multiples themselves — P/E, P/B, EV/EBITDA — read stock valuation multiples explained first. Nothing here is a view on any company.
The report usually reaches you as a screenshot. A logo, a rating, a target price and a percentage in green: "Target ₹1,450, 38% upside".
That screenshot is the least informative part of a thirty-page document. Everything that tells you whether the number deserves your attention is further in — in the forecast table, in a paragraph about valuation, and in two dense pages of disclosures at the back that almost nobody reads.
This is how I read one, in the order I read it.
# Step 1 — check the date and the price on that date
Before any analysis, find two things on the first page: the report date and the price the upside was calculated from.
Upside is always measured from the reference price on the date of the report. If the stock has moved 20% since then, the headline upside is simply out of date. A report published before the latest quarterly results may also be working from earnings estimates that the company has since beaten or missed.
Then check whether there is a newer report from the same broker. Forwarded screenshots often circulate for months after the analyst has revised the number.
# Step 2 — take the target price apart
Most target prices in Indian broker reports come from one of a handful of methods:
| Method | What the target is built from | Where it is common |
|---|---|---|
| P/E on forward EPS | Forecast earnings per share × a target P/E | Most manufacturing, consumer and IT companies |
| EV/EBITDA | Forecast EBITDA × a target multiple, less net debt, divided by shares | Capital-heavy businesses, telecom, cement |
| P/B or P/ABV | Forecast book value × a target multiple | Banks and NBFCs |
| DCF | Forecast cash flows discounted at an assumed cost of capital, plus a terminal value | Businesses with long, predictable cash flows |
| Sum of the parts (SOTP) | Each business valued separately, often with a holding-company discount | Conglomerates and groups with listed subsidiaries |
Whatever the method, the structure is the same: a forecast multiplied by a multiple someone chose. Both halves are assumptions. The report will usually show you the forecast in a table. The multiple is often justified in a single sentence.
The report will also tell you which year's earnings the multiple is applied to. A 30x multiple on earnings two years out is a very different claim from 30x on the current year. If this distinction is new to you, forward P/E vs trailing P/E explains it.
# A worked example — how much the multiple matters
Here is a simplified, hypothetical report on a company we will call Company X. It is illustrative only and does not describe any real company.
The analyst's assumptions:
- Revenue this year: ₹2,000 crore
- Revenue growth: 18% a year for two years
- Net profit margin two years out: 11%
- Shares outstanding: 10 crore
- Target multiple: 35x two-year-forward EPS
- Price on the report date: ₹900
What those assumptions produce:
- Revenue two years out: ₹2,784.8 crore
- Net profit: ₹306.3 crore
- EPS: ₹30.63
- Target price: ₹30.63 × 35 = ₹1,072
- Stated upside: 19.1%
Now change one assumption at a time, and then all three together:
| Scenario | Growth | Margin | Multiple | EPS (₹) | Target (₹) | Upside vs ₹900 |
|---|---|---|---|---|---|---|
| Report as written | 18% | 11.0% | 35x | 30.63 | 1,072 | 19.1% |
| Multiple 30x | 18% | 11.0% | 30x | 30.63 | 919 | 2.1% |
| Multiple 25x | 18% | 11.0% | 25x | 30.63 | 766 | −14.9% |
| Growth 12% | 12% | 11.0% | 35x | 27.60 | 966 | 7.3% |
| Margin 9.5% | 18% | 9.5% | 35x | 26.46 | 926 | 2.9% |
| Growth 12%, margin 9.5%, multiple 25x | 12% | 9.5% | 25x | 23.83 | 596 | −33.8% |
Three things fall out of this table.
The multiple does the heaviest lifting. Every 1x change in the multiple moves the target by one year's EPS — ₹30.63 here. Moving from 35x to 30x, a change most readers would not notice in a sentence, wipes out nearly all of the upside.
The price already implies a multiple. At ₹900, the market is paying about 29.4x the analyst's own two-year-forward EPS. The report's case, in plain words, is: "we think 35x is fair and the market thinks roughly 29x". That is a narrower and more testable claim than "19% upside".
Moderate assumption changes compound. None of the changes in the last row is extreme. Growth of 12% instead of 18%, a margin 1.5 points lower, a multiple of 25x instead of 35x — and the same arithmetic gives a number a third below the current price. When you see a precise target price, remember how wide the range around it really is.
# Step 3 — test each assumption against the company's own history
You do not need a model to do this. You need the company's last five years and the report's forecast table side by side.
Revenue growth. If the company grew revenue at 11% a year for the last five years and the report assumes 18% for the next two, the report owes you a reason — a new plant commissioned, a price increase, a large contract. Look for it in the text. If there is none, you have found the most fragile assumption. The CAGR calculator gives you the historical rate in a minute.
Margin. Compare the forecast margin with the company's own best and worst years, and with its closest peers. A forecast at or above the company's all-time best margin is an optimistic case, not a base case.
The target multiple. Ask three questions. What multiple has this stock traded at over the last five years, on average? What do comparable companies trade at? And why does the report think this company deserves a premium or a discount to both? "Re-rating" is a word that often carries a lot of the target price.
Quality of the earnings being multiplied. A multiple applied to earnings that do not convert into cash is a multiple applied to an accounting number. If the company's operating cash flow has been lagging its profit, the report may not mention it. The cash flow forensic guide shows you how to check.
# Step 4 — read the disclosures at the back
This is the part of the report most readers skip, and it is the part SEBI prescribes. The SEBI (Research Analysts) Regulations, 2014 — last amended on 6 August 2025 at the time of writing — require a research report to disclose a specific set of facts about the analyst, the firm and their relationship with the company being written about.
# What Regulation 19 requires the report to disclose
| Disclosure | What it tells you |
|---|---|
| Whether the analyst, the research entity, or their associates or relatives have any financial interest in the subject company, and its nature | Whether the author gains if the price goes up |
| Whether any of them has actual or beneficial ownership of 1% or more of the company's securities at the end of the month before publication | A significant holding by the writer's side |
| Any other material conflict of interest at the time of publication | A catch-all — read it, because firms use it for relationships that fit nowhere else |
| Whether the firm or its associates received any compensation from the company in the past twelve months | Any paying relationship at all |
| Whether they managed or co-managed a public offering for the company in the past twelve months | An IPO, QIP or similar issue handled by the same group |
| Whether they received compensation for investment banking, merchant banking or brokerage services from the company in the past twelve months | A commercial relationship with the company's finance function |
| Whether they received compensation for other products or services from the company, or any compensation or benefit from the company or a third party in connection with the report | Whether someone paid for this particular piece of research |
| Whether the analyst served as an officer, director or employee of the company | A former insider writing about the company |
| Whether the firm is engaged in market making in the company's securities | The firm has a trading position in the stock as part of its business |
Since the December 2024 amendment, Regulation 19 also requires a research analyst or research entity to disclose to the client the extent to which it uses artificial intelligence tools in providing research services.
A "yes" in any of these rows is not an accusation. Large Indian brokerages are also investment banks, and it would be surprising if they had no relationship with any large company. What the disclosure does is tell you how carefully to test the assumptions. A report from a firm that managed the company's last fund-raise deserves the full Step 3 treatment.
# What Regulation 20 requires on ratings and price history
- The report must define the terms it uses in recommendations and use them consistently.
- A firm that uses a rating system must clearly define the meaning of each rating, including the time horizon and the benchmark on which it is based.
- If the report contains a rating or price target and the firm has covered the stock with a rating or target for at least a year, it must include a graph of the daily closing price for the period covered or three years, whichever is shorter.
That price chart is worth a look. Many firms mark their previous ratings and targets on it, which lets you see how their past calls on this stock played out.
# A note on the analyst's own trading
Regulation 16 separately prohibits individual research analysts — independent, part-time, or employed by a research entity — and their associates from dealing in securities they recommend or follow within thirty days before and five days after a research report is published. This is not something you can verify from the report, but it is worth knowing the rule exists.
# What a research report is genuinely good for
It is easy to read an article like this as an attack on broker research. It is not. A good report does things an individual investor cannot easily do alone: it summarises management meetings, collects industry data, and sets out a forecast you can argue with. The forecast table is often the most useful page in the document.
The trouble starts only when the conclusion — one rating, one number — is treated as the content. The rating is the least transferable part of the report. The analysis behind it is what you can reuse.
A sensible habit is to strip the report down to four lines before you form any view:
- Date and reference price.
- Growth, margin and multiple assumed.
- How each compares with the company's own history.
- Relationships disclosed at the back.
If those four lines still make sense to you, the report has done its job. If they do not, the target price was never the point.
Check the fundamentals behind any report for yourself. Stock X-Ray shows a company's history, valuation and peers side by side, and Forensic Deep Analysis looks at earnings quality — educational tools for testing assumptions, not recommendations. Start free →
# References (verified 23 September 2026)
- SEBI — Securities and Exchange Board of India (Research Analysts) Regulations, 2014 [Last amended on August 6, 2025]: https://www.sebi.gov.in/legal/regulations/aug-2025/securities-and-exchange-board-of-india-research-analysts-regulations-2014-last-amended-on-august-6-2025-_96110.html
- SEBI — Securities and Exchange Board of India (Research Analysts) Regulations, 2014 [Last amended on December 16, 2024]: https://www.sebi.gov.in/legal/regulations/dec-2024/securities-and-exchange-board-of-india-research-analysts-regulations-2014-last-amended-on-december-16-2024-_90153.html
- SEBI — Master Circular for Research Analysts (SEBI/HO/MIRSD/MIRSD-PoD/P/CIR/2025/95, 27 June 2025): https://www.sebi.gov.in/legal/master-circulars/jun-2025/master-circular-for-research-analysts_94840.html
# Related reading
- Stock valuation multiples — P/E, P/B and EV/EBITDA explained
- Forward P/E vs trailing P/E
- Cash flow statement analysis — the forensic guide
- Sector-specific analysis frameworks for Indian stocks
Disclaimer: This article is educational and explains how to read published research critically. It is not investment advice and not a recommendation to buy, sell or hold any security, and it does not comment on any brokerage or any report. Company X and all figures in the worked example are hypothetical. VittSphere ONE is not a SEBI-registered Research Analyst or Investment Adviser; Stock X-Ray and Forensic Deep Analysis are educational tools and their output is not a recommendation. The regulatory provisions summarised here are paraphrased from the SEBI (Research Analysts) Regulations, 2014 as amended up to 6 August 2025; refer to the current text on sebi.gov.in before relying on them. Data verified 23 September 2026.
Run this analysis on any stock in seconds.
